# Lakewood-Amedex Biotherapeutics Inc.: filings

LABT · Nasdaq · CIK 2079272 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/labt.md) · [Financials](/companies/labt/financials.md) · [Filings](/companies/labt/filings.md) · [Insiders](/companies/labt/insiders.md)

## Reports and events: 15 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (424B3 6, 3 5, S-1/A 5, 8-K 4, EFFECT 3, S-1 3, SCHEDULE 13G 3, 10-Q 2, 424B4 2, DRS 2, 4 1, 8-A12B 1, CERT 1, CORRESP 1, DEF 14A 1, DEFA14A 1, DRS/A 1, PRE 14A 1, UPLOAD 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 17:49 ET | [8-K](/filings/0001213900-26-104177.md) | 5.07 Shareholder vote results | 0001213900-26-104177 |
| 2026-09-18 | 17:30 ET | [S-1](/filings/0001213900-26-101512.md) | Registration statement | 0001213900-26-101512 |
| 2026-08-14 | 21:36 ET | [10-Q](/filings/0001213900-26-089380.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089380 |
| 2026-08-10 | 17:13 ET | [DEF 14A](/filings/0001213900-26-087336.md) | Proxy statement, period 2026-09-22 | 0001213900-26-087336 |
| 2026-07-15 | 16:15 ET | [8-K](/filings/0001213900-26-078328.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-078328 |
| 2026-06-17 | 11:40 ET | [8-K](/filings/0001213900-26-069512.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-069512 |
| 2026-05-22 | 16:55 ET | [10-Q](/filings/0001213900-26-060640.md) | Quarterly report, period 2026-03-31 | 0001213900-26-060640 |
| 2026-05-01 | 16:05 ET | [S-1](/filings/0001213900-26-050936.md) | Registration statement | 0001213900-26-050936 |
| 2026-04-28 | 16:15 ET | [8-K](/filings/0001213900-26-048553.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-048553 |
| 2026-04-06 | 11:38 ET | [S-1/A](/filings/0001213900-26-040254.md) | Registration statement, amended | 0001213900-26-040254 |
| 2026-04-01 | 06:20 ET | [S-1/A](/filings/0001213900-26-037938.md) | Registration statement, amended | 0001213900-26-037938 |
| 2026-03-11 | 16:45 ET | [S-1/A](/filings/0001213900-26-026195.md) | Registration statement, amended | 0001213900-26-026195 |
| 2026-02-13 | 21:56 ET | [S-1/A](/filings/0001213900-26-015814.md) | Registration statement, amended | 0001213900-26-015814 |
| 2026-02-05 | 21:35 ET | [S-1/A](/filings/0001213900-26-012492.md) | Registration statement, amended | 0001213900-26-012492 |
| 2026-01-09 | 17:28 ET | [S-1](/filings/0001213900-26-003037.md) | Registration statement | 0001213900-26-003037 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.